GeneDx Holdings (WGS) Income from Continuing Operations (2020 - 2026)

GeneDx Holdings has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 63316000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 876.8% year-over-year to 63316000.0; the TTM figure through Mar 2026 stood at 77809000.0 (down 101.95% YoY), while the FY2025 annual figure was 21021000.0, up 59.8% from the prior year.
• Income from Continuing Operations declined to 63316000.0 in Q1 2026, from 17714000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for WGS reached as high as 10809000.0 in Q2 2025 and fell as low as 308719000.0 in Q4 2022.
• The 5-year median for Income from Continuing Operations is 29173000.0 (2024), against an average of 50662764.71.
• Annual changes were most pronounced in 2025 — Income from Continuing Operations jumped 137.05% — and 2026, when it tumbled 876.8%.
• A 5-year view of Income from Continuing Operations shows it stood at 308719000.0 in 2022, then surged by 91.66% to 25758000.0 in 2023, then soared by 121.11% to 5438000.0 in 2024, then plunged by 425.74% to 17714000.0 in 2025, then tumbled by 257.43% to 63316000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 63316000.0, 17714000.0, and 7588000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.